Latest Schedule 13G passive stakes

Balyasny Asset Management L.P. and affiliated entities have filed a Schedule 13G, reporting beneficial ownership of 4.84% of Rezolute, Inc. common stock.

Balyasny Asset Management L.P. and affiliated entities have filed a Schedule 13G amendment, reporting zero shares beneficially owned in Rallybio Corp.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 500,000 shares, representing 6.43% of Research Alliance Corporation III's Class A Common Stock.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 9.99% of Quince Therapeutics, Inc. common stock as of June 30, 2026.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 4.99% of Ovid Therapeutics Inc. common stock.

Balyasny Asset Management L.P. and affiliated entities have disclosed beneficial ownership of 9.99% of Nasus Pharma Ltd.'s common stock.

Balyasny Asset Management L.P. and affiliated entities have disclosed beneficial ownership of 818,706 shares, representing 5.18% of Neurogene Inc.'s common stock as of June 30, 2026.

Long Focus Capital Management, LLC and John Helmers report beneficial ownership of 6.0% of Standard BioTools Inc. common stock as of June 30, 2026.

Balyasny Asset Management and affiliated entities have disclosed beneficial ownership of 9.99% of Minerva Neurosciences' common stock, holding 4,654,212 shares.

Long Focus Capital Management, LLC and John Helmers report beneficial ownership of 4.9% of Aura Biosciences, Inc. common stock as of June 30, 2026.

Balyasny Asset Management L.P. and its affiliates have reported beneficial ownership of 9.99% of Lexeo Therapeutics, Inc. common stock, totaling 7,844,311 shares.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 951,783 shares, representing 6.6% of Korro Bio, Inc.'s common stock.

Balyasny Asset Management L.P. and affiliated entities have disclosed beneficial ownership of 500,000 shares, representing 6.23% of JATT II Acquisition Corp's common stock.

Balyasny Asset Management L.P. and affiliated entities have reported a beneficial ownership stake of 6.64% in Opus Genetics Inc., indicating a shift in institutional holding.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 6.97% of Helix Acquisition Corp. III's Class A Common Stock as of June 30, 2026.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 317,511 shares, representing 7.33% of Cyclerion Therapeutics, Inc. common stock.

Balyasny Asset Management L.P. and affiliated entities have reported an increase in their beneficial ownership of Contineum Therapeutics, Inc. Class A Common Stock to 7.14%.

Balyasny Asset Management L.P. and affiliated entities have reported a beneficial ownership of 9.99% in Cellectar Biosciences, Inc., following adjustments related to warrant exercises and ownership limitations.

Balyasny Asset Management L.P. and affiliated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of 4.99% of Camp4 Therapeutics Corp. common stock.

Ares Management Corporation's Schedule 13G filing reveals significant beneficial ownership by Ares Partners Holdco LLC and Ares Owners Holdings L.P., totaling 32.4% of Class A common stock.

Antony P. Ressler's Schedule 13G filing reveals increased beneficial ownership in Ares Management Corporation, now holding 33.1% of the class.

Axim Planning & Wealth has filed a Schedule 13G, disclosing beneficial ownership of 5.3% of EHang Holdings Limited's Class A Ordinary Shares as of June 30, 2026.

Motovance Holdings Limited and Li Wang report a combined 9.7% beneficial ownership of Park Ha Biological Technology's Class A Ordinary Shares following warrant exercise.

A significant stakeholder group, BSIV Hold 101, LP and affiliated entities, has reported beneficial ownership of 15.02% of Neptune Insurance Holdings Inc.'s Class A Common Stock.

Charles Edwin Young and Keystone Cranberry, LLC report increased beneficial ownership of Smart Sand, Inc. common stock, now holding a combined 31% stake.

Several PEAK6 affiliated entities and individuals have reported beneficial ownership of approximately 6.6% of Ring Energy, Inc.'s common stock as of June 30, 2026.

Multiple JFL-affiliated entities have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 13.5% of DPC Holdings PLC's ordinary shares.

Joseph D. Samberg and his Revocable Trust report a combined beneficial ownership of 13,110,000 shares, representing 7.77% of NextNav Inc.'s common stock, as of June 30, 2026.

Wilco 63 Corp's Schedule 13G filing reveals that Wilco 63 Holding LLC, HandsOn Global Management LLC, and Par Chadha collectively beneficially own 20% of the company's Class A Ordinary Shares through convertible Class B shares.

A group of investment entities, led by Neos Partners, has disclosed beneficial ownership of over 51% of Forgent Power Solutions' Class A Common Stock.